SCHEMBL3945142

SCHEMBL3945142

CN(C)C[CH]CN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4265793 0.81
SCHEMBL1841092 0.78
SCHEMBL1060177 0.78
SCHEMBL5948694 0.75
Hydrochloric Acid SCHEMBL6202258 0.75
SCHEMBL5749958 0.75 ALDH1A1 (0.35)
SCHEMBL8524796 0.73
SCHEMBL4365509 0.73 TSHR (0.36)
SCHEMBL235759 0.73 KDM4E (0.36)
SCHEMBL317785 0.73 KDM4E (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006094556-A1 POLYELECTROLYTES BASED ON DIQUATERNARY DI-AMMONIUM MONOMERS TAMINCO N.V. (BE) 2006-09-14 WO claimed
EP-1648426-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LTD (GB) 2014-01-08 EP disclosed
EP-2049516-A2 PHARMACEUTICAL COMPOUNDS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2008007123-A2 PHARMACEUTICAL COMPOUNDS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed
WO-2006094556-A1 POLYELECTROLYTES BASED ON DIQUATERNARY DI-AMMONIUM MONOMERS TAMINCO N.V. (BE) 2006-09-14 WO disclosed
US-6841697-B2 Process for preparing 2-(dimethylamino)-1-(dimethyl-aminomethyl) ethyl meth (acrylate) ATOFINA (FR) 2005-01-11 US disclosed
JP-2002363145-A METHOD FOR PRODUCING 2-(DIMETHYLAMINO)-1-(DIMETHYLAMINOMETHYL)ETHYL METH(ACRYLATE) ATOFINA 2002-12-18 JP disclosed
JP-2002363145-A METHOD FOR PRODUCING 2-(DIMETHYLAMINO)-1-(DIMETHYLAMINOMETHYL)ETHYL METH(ACRYLATE) ATOFINA 2002-12-18 JP disclosed
US-20020183543-A1 Process for preparing 2-(dimethylamino)-1-(dimethyl-aminomethyl) ethyl meth (acrylate) ATOFINA (FR) 2002-12-05 US disclosed
US-6004823-A Compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-12-21 US disclosed
US-6001850-A HAVING GONADOTROPIN-RELEASING HORMONE ANTAGONISTIC ACTIVITY ARE USEFUL AS PROPHYLACTIC OR THERAPEUTIC AGENTS FOR THE PREVENTION OR TREATMENT OF SEVERAL HORMONE DEPENDENT DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-14 US disclosed
US-5977132-A GALACTORRHEA, HYPERPROLACTINEMIC OVULATION, PROLACTINOMA AND BRAIN TUMORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-11-02 US disclosed
EP-0781774-A2 Prolactin production inhibitory agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-07-02 EP disclosed
EP-0091057-B1 5,6-DIHYDRO-11-ALKYLENE-MOPHANTRIDIN-6-ONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BASF Aktiengesellschaft (DE) 1986-06-11 EP disclosed
US-4347182-A Preparation of penicillanic acid derivatives BEECHAM GROUP LIMITED (GB) 1982-08-31 US disclosed